NANOLEK Competitors and Similar CompaniesClear all
NANOLEK's competitors and similar companies include Benchmark Research, UCB, Livzon Pharmaceutical Group and Alembic Pharmaceuticals.
 Benchmark Research Benchmark Research is a clinical research firm that conducts investigational studies for the development of vaccines and medicines. |  UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. |  Livzon Pharmaceutical Group Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products. |  Alembic Pharmaceuticals Alembic Pharmaceuticals is a company that develops, manufactures, and markets pharmaceutical products, pharmaceutical substances, and intermediates | ||
Founding Date | Founding Date 2011 | Founding Date 1997 | Founding Date 1928 | Founding Date 1985 | Founding Date 2010 |
Type | Type Private | Type Private | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Moskva, RU HQ | Locations Austin, US HQ Colton, US Fort Worth, US Metairie, US Sacramento, US San Angelo, US San Francisco, US see more | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more | Locations Zhuhai, CN HQ Chengdu, CN Qingyuan, CN Shanghai, CN Shaoguan, CN Shenzhen, CN Zhuhai, CN | Locations Vadodara, IN HQ Baska, IN Mumbai, IN Namthang, IN Vadodara, IN Vadodara, IN |
Employees | Employees 85 | Employees 719% decrease | Employees 9,052 | Employees 9,067 | Employees 14,858 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 34.3 b | Valuation ($) 4.2 b | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) €7.4b (FY, 2025) | Revenue (est.) ¥11.7b (FY, 2025) | Revenue (est.) ₹73.4b (FY, 2026) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods €1.4b (FY, 2025) | Cost of goods ¥4.1b (FY, 2025) | Cost of goods ₹19.8b (FY, 2026) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit €7.2b (FY, 2025) | Gross profit ¥7.8b (FY, 2025) | Gross profit ₹54.1b (FY, 2026) |
Net income | Net income N/A | Net income N/A | Net income €1.6b (FY, 2025) | Net income ¥2.4b (FY, 2025) | Net income ₹6.7b (FY, 2026) |
For sources of this data, please see the company profile
View Company Profiles
Benchmark Research
HQ
Austin, US
Employees
71↓ 9% decrease
Benchmark Research is a clinical research firm that conducts investigational studies for the development of vaccines and medicines.
View companyUCB
HQ
Brussels, BE
Employees
9,052
UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
View companyLivzon Pharmaceutical Group
HQ
Zhuhai, CN
Employees
9,067
Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products.
View companyAlembic Pharmaceuticals
HQ
Vadodara, IN
Employees
14,858
Alembic Pharmaceuticals is a company that develops, manufactures, and markets pharmaceutical products, pharmaceutical substances, and intermediates
View company